MTR: Injectable Drug
Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal,
Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin,
Musculoskeletal), End User - Global Forecast to 2020
Summary
The injectable drug delivery market is expected to reach $547.8
billion by 2020 from $326.1 billion in 2015, growing at a CAGR of 12.0% from
2015 to 2020. The market is categorized on the basis of type, therapeutic
application, usage pattern, mode of administration, end user, and region. The
therapeutic application market is further segmented into autoimmune diseases,
hormonal disorders, oncology, orphan diseases, and other therapeutic
applications. The oncology segment is expected to witness the highest CAGR in
the forecast period.
Factors such as rising incidences of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements, are driving the growth of the injectable drug delivery market. In addition, emphasis on innovation of formulations and improving the delivery of pharmaceuticals is also contributing to the growth of the market. For instance, in November 2012, COMPACT (Collaboration on the Optimization of Macromolecular Pharmaceutical Access to Cellular Targets), a public-private consortium funded by the Innovative Medicines Initiative (IMI), announced the launch of a €30 million ($38.5 million) project, which focuses on improving the delivery of biopharmaceuticals. The consortium would address the major bottlenecks in the development of novel innovative medicines based on Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
Factors such as rising incidences of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements, are driving the growth of the injectable drug delivery market. In addition, emphasis on innovation of formulations and improving the delivery of pharmaceuticals is also contributing to the growth of the market. For instance, in November 2012, COMPACT (Collaboration on the Optimization of Macromolecular Pharmaceutical Access to Cellular Targets), a public-private consortium funded by the Innovative Medicines Initiative (IMI), announced the launch of a €30 million ($38.5 million) project, which focuses on improving the delivery of biopharmaceuticals. The consortium would address the major bottlenecks in the development of novel innovative medicines based on Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
biological macromolecules, such as proteins/peptides and
oligonucleotides. Such investments are fueling the growth of the market.
Asia is expected to be the fastest-growing country in the injectable drug delivery market. High growth in this market can be attributed to the increased demand for injectable insulin and self-injection devices, particularly pen injectors which are used in the treatment of diabetes.
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the injectable drug delivery market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the injectable drug delivery market. The report analyzes this market by type, therapeutic application, usage pattern, mode of administration, end user, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the injectable drug delivery market
• Competitive Assessment: In-depth assessment of market strategies, geographical and
Asia is expected to be the fastest-growing country in the injectable drug delivery market. High growth in this market can be attributed to the increased demand for injectable insulin and self-injection devices, particularly pen injectors which are used in the treatment of diabetes.
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the injectable drug delivery market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the injectable drug delivery market. The report analyzes this market by type, therapeutic application, usage pattern, mode of administration, end user, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the injectable drug delivery market
• Competitive Assessment: In-depth assessment of market strategies, geographical and
Get Full Report With
Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
business segments, and product portfolios of leading players in
the injectable drug delivery market
• Market Development: Comprehensive information about lucrative markets. The report analyzes the market for various injectable drug delivery across countries
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the injectable drug delivery market
• Market Development: Comprehensive information about lucrative markets. The report analyzes the market for various injectable drug delivery across countries
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the injectable drug delivery market
Table of contents
1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 YEARS CONSIDERED FOR THE STUDY 28
1.4 CURRENCY 28
1.5 LIMITATIONS 28
1.6 STAKEHOLDERS 28
2 RESEARCH METHODOLOGY 29
2.1 MARKET SIZE ESTIMATION 30
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 32
2.3 KEY DATA FROM SECONDARY SOURCES 34
2.4 KEY DATA FROM PRIMARY SOURCES 34
2.5 ASSUMPTIONS FOR THE STUDY 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHTS 39
4.1 INJECTABLE DRUG DELIVERY MARKET, BY FORMULATION 39
4.2 INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN 39
4.3 INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION 40
4.4 INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION 41
4.5 GEOGRAPHICAL SNAPSHOT OF THE INJECTABLE DRUG DELIVERY MARKET 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 44
5.2 MARKET SEGMENTATION 44
5.2.1 BY TYPE 45
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 YEARS CONSIDERED FOR THE STUDY 28
1.4 CURRENCY 28
1.5 LIMITATIONS 28
1.6 STAKEHOLDERS 28
2 RESEARCH METHODOLOGY 29
2.1 MARKET SIZE ESTIMATION 30
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 32
2.3 KEY DATA FROM SECONDARY SOURCES 34
2.4 KEY DATA FROM PRIMARY SOURCES 34
2.5 ASSUMPTIONS FOR THE STUDY 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHTS 39
4.1 INJECTABLE DRUG DELIVERY MARKET, BY FORMULATION 39
4.2 INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN 39
4.3 INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION 40
4.4 INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION 41
4.5 GEOGRAPHICAL SNAPSHOT OF THE INJECTABLE DRUG DELIVERY MARKET 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 44
5.2 MARKET SEGMENTATION 44
5.2.1 BY TYPE 45
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
5.2.2 BY THERAPEUTIC APPLICATION 45
5.2.3 BY USAGE PATTERN 46
5.2.4 BY MODE OF ADMINISTRATION 46
5.2.5 BY END USER 46
5.2.6 BY REGION 47
5.3 MARKET DYNAMICS 47
?
5.4 DRIVERS 49
5.4.1 RISING PREVALENCE OF CHRONIC DISEASES 49
5.4.2 INCREASE IN DEMAND FOR SELF-INJECTION DEVICES 50
5.4.3 GROWTH OF THE BIOLOGICS MARKET 50
5.4.4 TECHNOLOGICAL ADVANCEMENTS 50
5.5 RESTRAINTS 52
5.5.1 NEEDLESTICK INJURIES AND INFECTIONS 52
5.6 OPPORTUNITIES 53
5.6.1 INCREASE IN DEMAND FOR BIOSIMILARS AND GENERIC INJECTABLES 53
5.6.1.1 Biosimilars 53
5.6.1.2 Generic injectables 53
5.6.2 CONTRACEPTIVE INJECTABLES 54
5.7 CHALLENGES 55
5.7.1 PRODUCT RECALLS 55
5.7.2 REGULATORY HURDLES 56
5.7.3 STABILITY OF PRODUCTS 57
5.7.4 STERILITY OF INJECTIONS 57
5.7.5 PREFERENCE FOR OTHER MODES OF DRUG DELIVERY 58
6 INJECTABLE DRUG DELIVERY MARKET, BY TYPE 60
6.1 INTRODUCTION 61
6.2 DEVICES 62
6.2.1 CONVENTIONAL INJECTION DEVICES 63
6.2.1.1 By Material 64
6.2.1.1.1 Glass 65
6.2.1.1.2 Plastic 66
6.2.1.2 By Product 67
6.2.1.2.1 Fillable syringes 67
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
5.2.3 BY USAGE PATTERN 46
5.2.4 BY MODE OF ADMINISTRATION 46
5.2.5 BY END USER 46
5.2.6 BY REGION 47
5.3 MARKET DYNAMICS 47
?
5.4 DRIVERS 49
5.4.1 RISING PREVALENCE OF CHRONIC DISEASES 49
5.4.2 INCREASE IN DEMAND FOR SELF-INJECTION DEVICES 50
5.4.3 GROWTH OF THE BIOLOGICS MARKET 50
5.4.4 TECHNOLOGICAL ADVANCEMENTS 50
5.5 RESTRAINTS 52
5.5.1 NEEDLESTICK INJURIES AND INFECTIONS 52
5.6 OPPORTUNITIES 53
5.6.1 INCREASE IN DEMAND FOR BIOSIMILARS AND GENERIC INJECTABLES 53
5.6.1.1 Biosimilars 53
5.6.1.2 Generic injectables 53
5.6.2 CONTRACEPTIVE INJECTABLES 54
5.7 CHALLENGES 55
5.7.1 PRODUCT RECALLS 55
5.7.2 REGULATORY HURDLES 56
5.7.3 STABILITY OF PRODUCTS 57
5.7.4 STERILITY OF INJECTIONS 57
5.7.5 PREFERENCE FOR OTHER MODES OF DRUG DELIVERY 58
6 INJECTABLE DRUG DELIVERY MARKET, BY TYPE 60
6.1 INTRODUCTION 61
6.2 DEVICES 62
6.2.1 CONVENTIONAL INJECTION DEVICES 63
6.2.1.1 By Material 64
6.2.1.1.1 Glass 65
6.2.1.1.2 Plastic 66
6.2.1.2 By Product 67
6.2.1.2.1 Fillable syringes 67
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
6.2.1.2.2 Prefilled syringes 68
6.2.1.3 By Usability 69
6.2.1.3.1 Reusable syringes 69
6.2.1.3.2 Disposable syringes 70
6.2.2 SELF-INJECTION DEVICES 70
6.2.2.1 Needle-free injectors 72
6.2.2.1.1 By product 73
6.2.2.1.1.1 Fillable needle-free injectors 73
6.2.2.1.1.2 Prefilled needle-free injectors 74
6.2.2.1.2 By technology 74
6.2.2.1.2.1 Jet-based needle-free injectors 75
6.2.2.1.2.2 Spring-based Needle-free injectors 75
6.2.2.1.2.3 Laser-powered needle-free injectors 76
6.2.2.1.2.4 Vibration-based needle-free injectors 77
6.2.2.1.3 By usability 77
6.2.2.1.3.1 Reusable needle-free injectors 78
6.2.2.1.3.2 Disposable needle-free injectors 79
6.2.2.2 Autoinjectors 79
6.2.2.2.1 By product 80
6.2.2.2.1.1 Fillable Autoinjectors 80
6.2.2.2.1.2 Prefilled Autoinjectors 81
6.2.2.2.2 By technology 82
6.2.2.2.2.1 Automated Autoinjectors 82
6.2.2.2.2.2 Manual Autoinjectors 83
6.2.2.2.3 By design 83
6.2.2.2.3.1 Standardized Autoinjectors 84
6.2.2.2.3.2 Customized Autoinjectors 85
6.2.2.2.4 By usability 85
6.2.2.2.4.1 Reusable Autoinjectors 86
6.2.2.2.4.2 Disposable Autoinjectors 87
6.2.2.3 Pen injectors 87
6.2.2.3.1 By product 88
6.2.2.3.1.1 Single-chambered Pen Injectors 89
6.2.2.3.1.2 Dual-chambered Pen Injectors 89
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
6.2.1.3 By Usability 69
6.2.1.3.1 Reusable syringes 69
6.2.1.3.2 Disposable syringes 70
6.2.2 SELF-INJECTION DEVICES 70
6.2.2.1 Needle-free injectors 72
6.2.2.1.1 By product 73
6.2.2.1.1.1 Fillable needle-free injectors 73
6.2.2.1.1.2 Prefilled needle-free injectors 74
6.2.2.1.2 By technology 74
6.2.2.1.2.1 Jet-based needle-free injectors 75
6.2.2.1.2.2 Spring-based Needle-free injectors 75
6.2.2.1.2.3 Laser-powered needle-free injectors 76
6.2.2.1.2.4 Vibration-based needle-free injectors 77
6.2.2.1.3 By usability 77
6.2.2.1.3.1 Reusable needle-free injectors 78
6.2.2.1.3.2 Disposable needle-free injectors 79
6.2.2.2 Autoinjectors 79
6.2.2.2.1 By product 80
6.2.2.2.1.1 Fillable Autoinjectors 80
6.2.2.2.1.2 Prefilled Autoinjectors 81
6.2.2.2.2 By technology 82
6.2.2.2.2.1 Automated Autoinjectors 82
6.2.2.2.2.2 Manual Autoinjectors 83
6.2.2.2.3 By design 83
6.2.2.2.3.1 Standardized Autoinjectors 84
6.2.2.2.3.2 Customized Autoinjectors 85
6.2.2.2.4 By usability 85
6.2.2.2.4.1 Reusable Autoinjectors 86
6.2.2.2.4.2 Disposable Autoinjectors 87
6.2.2.3 Pen injectors 87
6.2.2.3.1 By product 88
6.2.2.3.1.1 Single-chambered Pen Injectors 89
6.2.2.3.1.2 Dual-chambered Pen Injectors 89
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
6.2.2.3.2 By design 90
6.2.2.3.2.1 Standard Pen Injectors 90
6.2.2.3.2.2 Customized Pen Injectors 91
6.2.2.3.3 By usability 91
6.2.2.3.3.1 Reusable Pen Injectors 92
6.2.2.3.3.2 Disposable Pen Injectors 92
6.2.2.4 Wearable injectors 93
6.2.2.5 Other Devices 94
6.3 FORMULATIONS 94
6.3.1 CONVENTIONAL DRUG DELIVERY 96
6.3.1.1 SOLUTIONS 97
6.3.1.2 RECONSTITUTED/LYOPHILIZED FORMULATIONS 97
6.3.1.3 SUSPENSIONS 98
6.3.1.4 EMULSIONS 99
6.3.2 NOVEL DRUG DELIVERY FORMULATIONS 99
6.3.2.1 COLLOIDAL DISPERSIONS 101
6.3.2.1.1 LIPOSOMES 102
6.3.2.1.2 NIOSOMES 102
6.3.2.1.3 POLYMERIC/MIXED MICELLES 103
6.3.2.1.4 NANOPARTICLES 104
6.3.2.1.4.1 NANOSUSPENSIONS 105
6.3.2.1.4.2 NANOEMULSIONS/MICROEMULSIONS 105
6.3.2.1.4.3 SOLID-LIPID NANOPARTICLES 106
6.3.2.2 MICROPARTICLES 106
6.3.2.2.1 MICROSPHERES 107
6.3.2.2.2 MICROCAPSULES 108
6.3.3 LONG-ACTING INJECTION FORMULATIONS 109
7 INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION 110
7.1 INTRODUCTION 111
7.2 AUTOIMMUNE DISEASES 113
7.2.1 RHEUMATOID ARTHRITIS 114
7.2.2 MULTIPLE SCLEROSIS 115
7.2.3 CROHN’S DISEASE 116
7.2.4 PSORIASIS 117
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
6.2.2.3.2.1 Standard Pen Injectors 90
6.2.2.3.2.2 Customized Pen Injectors 91
6.2.2.3.3 By usability 91
6.2.2.3.3.1 Reusable Pen Injectors 92
6.2.2.3.3.2 Disposable Pen Injectors 92
6.2.2.4 Wearable injectors 93
6.2.2.5 Other Devices 94
6.3 FORMULATIONS 94
6.3.1 CONVENTIONAL DRUG DELIVERY 96
6.3.1.1 SOLUTIONS 97
6.3.1.2 RECONSTITUTED/LYOPHILIZED FORMULATIONS 97
6.3.1.3 SUSPENSIONS 98
6.3.1.4 EMULSIONS 99
6.3.2 NOVEL DRUG DELIVERY FORMULATIONS 99
6.3.2.1 COLLOIDAL DISPERSIONS 101
6.3.2.1.1 LIPOSOMES 102
6.3.2.1.2 NIOSOMES 102
6.3.2.1.3 POLYMERIC/MIXED MICELLES 103
6.3.2.1.4 NANOPARTICLES 104
6.3.2.1.4.1 NANOSUSPENSIONS 105
6.3.2.1.4.2 NANOEMULSIONS/MICROEMULSIONS 105
6.3.2.1.4.3 SOLID-LIPID NANOPARTICLES 106
6.3.2.2 MICROPARTICLES 106
6.3.2.2.1 MICROSPHERES 107
6.3.2.2.2 MICROCAPSULES 108
6.3.3 LONG-ACTING INJECTION FORMULATIONS 109
7 INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION 110
7.1 INTRODUCTION 111
7.2 AUTOIMMUNE DISEASES 113
7.2.1 RHEUMATOID ARTHRITIS 114
7.2.2 MULTIPLE SCLEROSIS 115
7.2.3 CROHN’S DISEASE 116
7.2.4 PSORIASIS 117
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
7.2.5 OTHER AUTOIMMUNE DISEASES 118
7.3 HORMONAL DISORDERS 119
7.3.1 DIABETES 120
7.3.2 ANEMIA 121
7.3.3 REPRODUCTIVE HEALTH DISEASE 121
7.3.4 ANTITHROMBOTIC/THROMBOLYTIC THERAPY 122
7.3.5 OSTEOPOROSIS 123
7.3.6 GROWTH HORMONE DEFICIENCY (GHD) 124
7.4 ORPHAN DISEASES 125
7.5 ONCOLOGY 126
7.6 OTHERS 127
7.6.1 PAIN MANAGEMENT 128
7.6.2 ALLERGY TREATMENT 129
7.6.3 AESTHETIC TREATMENTS 130
7.6.4 HEPATITIS C 130
7.6.5 HEMOPHILIA 131
8 INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN 133
8.1 INTRODUCTION 134
8.2 CURATIVE CARE 135
8.3 IMMUNIZATION 135
8.4 OTHER USAGE PATTERNS (BLOOD TRANSFUSION AND BLOOD PRODUCTS, AND CONTRACEPTIVES) 137
9 INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION 138
9.1 INTRODUCTION 139
9.2 SKIN 140
9.3 CIRCULATORY/MUSCULOSKELETAL 140
9.4 ORGANS 141
9.5 CENTRAL NERVOUS SYSTEM 142
10 INJECTABLE DRUG DELIVERY MARKET, BY END USER 143
10.1 INTRODUCTION 144
10.2 HOSPITALS AND CLINICS 146
10.3 HOME CARE SETTINGS 146
10.4 RESEARCH LABORATORIES 147
10.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 148
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
7.3 HORMONAL DISORDERS 119
7.3.1 DIABETES 120
7.3.2 ANEMIA 121
7.3.3 REPRODUCTIVE HEALTH DISEASE 121
7.3.4 ANTITHROMBOTIC/THROMBOLYTIC THERAPY 122
7.3.5 OSTEOPOROSIS 123
7.3.6 GROWTH HORMONE DEFICIENCY (GHD) 124
7.4 ORPHAN DISEASES 125
7.5 ONCOLOGY 126
7.6 OTHERS 127
7.6.1 PAIN MANAGEMENT 128
7.6.2 ALLERGY TREATMENT 129
7.6.3 AESTHETIC TREATMENTS 130
7.6.4 HEPATITIS C 130
7.6.5 HEMOPHILIA 131
8 INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN 133
8.1 INTRODUCTION 134
8.2 CURATIVE CARE 135
8.3 IMMUNIZATION 135
8.4 OTHER USAGE PATTERNS (BLOOD TRANSFUSION AND BLOOD PRODUCTS, AND CONTRACEPTIVES) 137
9 INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION 138
9.1 INTRODUCTION 139
9.2 SKIN 140
9.3 CIRCULATORY/MUSCULOSKELETAL 140
9.4 ORGANS 141
9.5 CENTRAL NERVOUS SYSTEM 142
10 INJECTABLE DRUG DELIVERY MARKET, BY END USER 143
10.1 INTRODUCTION 144
10.2 HOSPITALS AND CLINICS 146
10.3 HOME CARE SETTINGS 146
10.4 RESEARCH LABORATORIES 147
10.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 148
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
10.6 OTHER END USERS 149
11 INJECTABLE DRUG DELIVERY MARKET, BY REGION 150
11.1 INTRODUCTION 151
11.2 NORTH AMERICA 152
11.2.1 U.S. 157
11.2.2 CANADA 161
11.3 EUROPE 164
11.3.1 GERMANY 170
11.3.2 FRANCE 173
11.3.3 U.K. 177
11.3.4 ITALY 180
11.3.5 SPAIN 184
11.3.6 REST OF EUROPE (ROE) 187
11.4 ASIA 192
11.5 REST OF THE WORLD (ROW) 197
12 COMPETITIVE LANDSCAPE 202
12.1 OVERVIEW 202
12.2 MARKET SHARE ANALYSIS 203
12.3 COMPETITIVE SITUATIONS & TRENDS 204
12.3.1 NEW PRODUCT LAUNCHES 205
12.3.2 EXPANSIONS AND INVESTMENTS 207
12.3.3 ACQUISITIONS 208
12.3.4 COLLABORATIONS 209
13 COMPANY PROFILES 210
13.1 INTRODUCTION 210
13.2 BAXTER INTERNATIONAL, INC. 211
13.2.1 BUSINESS OVERVIEW 211
13.2.2 PRODUCT OFFERINGS 212
13.2.3 RECENT DEVELOPMENTS 212
13.2.4 MNM VIEW 213
?
13.3 BECTON, DICKINSON AND COMPANY 214
13.3.1 BUSINESS OVERVIEW 214
13.3.2 PRODUCT OFFERINGS 215
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
11 INJECTABLE DRUG DELIVERY MARKET, BY REGION 150
11.1 INTRODUCTION 151
11.2 NORTH AMERICA 152
11.2.1 U.S. 157
11.2.2 CANADA 161
11.3 EUROPE 164
11.3.1 GERMANY 170
11.3.2 FRANCE 173
11.3.3 U.K. 177
11.3.4 ITALY 180
11.3.5 SPAIN 184
11.3.6 REST OF EUROPE (ROE) 187
11.4 ASIA 192
11.5 REST OF THE WORLD (ROW) 197
12 COMPETITIVE LANDSCAPE 202
12.1 OVERVIEW 202
12.2 MARKET SHARE ANALYSIS 203
12.3 COMPETITIVE SITUATIONS & TRENDS 204
12.3.1 NEW PRODUCT LAUNCHES 205
12.3.2 EXPANSIONS AND INVESTMENTS 207
12.3.3 ACQUISITIONS 208
12.3.4 COLLABORATIONS 209
13 COMPANY PROFILES 210
13.1 INTRODUCTION 210
13.2 BAXTER INTERNATIONAL, INC. 211
13.2.1 BUSINESS OVERVIEW 211
13.2.2 PRODUCT OFFERINGS 212
13.2.3 RECENT DEVELOPMENTS 212
13.2.4 MNM VIEW 213
?
13.3 BECTON, DICKINSON AND COMPANY 214
13.3.1 BUSINESS OVERVIEW 214
13.3.2 PRODUCT OFFERINGS 215
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
13.3.3 RECENT DEVELOPMENTS 215
13.3.4 MNM VIEW 216
13.4 GERRESHEIMER AG 217
13.4.1 BUSINESS OVERVIEW 217
13.4.2 PRODUCTS OFFERED 217
13.4.3 RECENT DEVELOPMENTS 218
13.4.4 MNM VIEW 218
13.5 PFIZER, INC. 219
13.5.1 BUSINESS OVERVIEW 219
13.5.2 PRODUCTS OFFERED 220
13.5.3 RECENT DEVELOPMENTS 221
13.5.4 MNM VIEW 221
13.6 SCHOTT AG 222
13.6.1 BUSINESS OVERVIEW 222
13.6.2 PRODUCT OFFERINGS 223
13.6.3 RECENT DEVELOPMENTS 223
13.6.4 MNM VIEW 223
13.7 ALKERMES PLC 224
13.7.1 BUSINESS OVERVIEW 224
13.7.2 PRODUCTS OFFERED 224
13.7.3 RECENT DEVELOPMENTS 225
13.8 ELI LILLY AND COMPANY 226
13.8.1 BUSINESS OVERVIEW 226
13.8.2 PRODUCTS OFFERED 227
13.8.3 RECENT DEVELOPMENTS 227
13.9 SANDOZ 228
13.9.1 BUSINESS OVERVIEW 228
13.9.2 PRODUCTS OFFERED 229
13.9.3 RECENT DEVELOPMENTS 230
13.10 TERUMO CORPORATION 231
13.10.1 BUSINESS OVERVIEW 231
13.10.2 PRODUCTS OFFERED 232
13.10.3 RECENT DEVELOPMENTS 232
13.11 TEVA PHARMACEUTICAL INDUSTRIES LTD. 233
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
13.3.4 MNM VIEW 216
13.4 GERRESHEIMER AG 217
13.4.1 BUSINESS OVERVIEW 217
13.4.2 PRODUCTS OFFERED 217
13.4.3 RECENT DEVELOPMENTS 218
13.4.4 MNM VIEW 218
13.5 PFIZER, INC. 219
13.5.1 BUSINESS OVERVIEW 219
13.5.2 PRODUCTS OFFERED 220
13.5.3 RECENT DEVELOPMENTS 221
13.5.4 MNM VIEW 221
13.6 SCHOTT AG 222
13.6.1 BUSINESS OVERVIEW 222
13.6.2 PRODUCT OFFERINGS 223
13.6.3 RECENT DEVELOPMENTS 223
13.6.4 MNM VIEW 223
13.7 ALKERMES PLC 224
13.7.1 BUSINESS OVERVIEW 224
13.7.2 PRODUCTS OFFERED 224
13.7.3 RECENT DEVELOPMENTS 225
13.8 ELI LILLY AND COMPANY 226
13.8.1 BUSINESS OVERVIEW 226
13.8.2 PRODUCTS OFFERED 227
13.8.3 RECENT DEVELOPMENTS 227
13.9 SANDOZ 228
13.9.1 BUSINESS OVERVIEW 228
13.9.2 PRODUCTS OFFERED 229
13.9.3 RECENT DEVELOPMENTS 230
13.10 TERUMO CORPORATION 231
13.10.1 BUSINESS OVERVIEW 231
13.10.2 PRODUCTS OFFERED 232
13.10.3 RECENT DEVELOPMENTS 232
13.11 TEVA PHARMACEUTICAL INDUSTRIES LTD. 233
Get Full Report With Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
13.11.1 BUSINESS OVERVIEW 233
13.11.2 PRODUCT OFFERINGS 234
13.11.3 RECENT DEVELOPMENTS 234
?
14 APPENDIX 235
14.1 INSIGHTS FROM INDUSTRY EXPERTS 235
14.2 DISCUSSION GUIDE 236
14.3 OTHER RECENT DEVELOPMENTS 239
14.4 AVAILABLE CUSTOMIZATIONS 240
14.5 RT: REAL-TIME MARKET INTELLIGENCE 240
14.6 RELATED REPORTS 241
13.11.2 PRODUCT OFFERINGS 234
13.11.3 RECENT DEVELOPMENTS 234
?
14 APPENDIX 235
14.1 INSIGHTS FROM INDUSTRY EXPERTS 235
14.2 DISCUSSION GUIDE 236
14.3 OTHER RECENT DEVELOPMENTS 239
14.4 AVAILABLE CUSTOMIZATIONS 240
14.5 RT: REAL-TIME MARKET INTELLIGENCE 240
14.6 RELATED REPORTS 241
Get Full Report With
Table Of http://marketstoreports.com/products/injectable-drug-delivery-market-by-type-device-formulation-therapeutic-hormonal-oncology-usage-pattern-curative-care-immunization-administration-skin-musculoskeletal-end-user-global-forecast-to-2020
About Us:
Markets to Reports is an effort to assist
you with the required market intelligence statistics matching your specific
requirements linked to various products, industries, services, companies and
trends etc. We partner with the best of the publishers across the globe
updating our database on a real time basis giving you easy access to the
information that you are interested in. We cater to conglomerates ranging from
start-ups to mid-size to Fortune 500 companies.
Our database of reports focus on various verticals/domains
including IT, Telecom & Networking, Engineering & Automation, Food
& Retail, Healthcare, Chemical, Energy, etc.
Your success is our accomplishment!
For More Information –
Please call us or write to us:
UK: +44-333-011-9100
Follow Us –
Browse Blog at http://marketstoreports.wordpress.com/
No comments:
Post a Comment